Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
DMexco ’26 Briefing: From scaling AI operations to teaching the next generation of ‘bold’ CMOs
DMexco 2026 media partner Digiday hosted two panels that outlined the challenge of AI at scale and the CMO of the future.
Marketers bemoan the culture of ‘good enough’ as standards fall amid the AI bubble
‘Drowning in measurement,’ marketers mull priorities in an internet where ‘two audiences’ exist.
Future of Marketing Briefing: Imagining the ad business hiding inside Meta’s Muse
Meta’s Muse is ad-free for now. Don’t expect that to last.